Vongsumran Nuttawut, Buranapin Supawan, Manosroi Worapaka
Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Diabetes Metab Syndr Obes. 2020 Jul 22;13:2593-2601. doi: 10.2147/DMSO.S262444. eCollection 2020.
Optimized postoperative blood glucose control can minimize postoperative complications. Conventional perioperative glycemic control protocol (CG), which has been routinely used in our institution, lacks detailed perioperative glycemic management. A new standardized glycemic control protocol (SG) was designed which employs frequent postoperative monitoring of blood glucose, more tightly targeted blood glucose control, and adjustment of insulin dosage prior to surgery. This study compared the efficacy of postoperative glycemic control and complications with the two protocols, CG and SG.
Three hundred and eighty type 2 diabetes patients who underwent elective surgeries were included in the study. Of those, 182 patients with CG were identified retrospectively as a historical control cohort. Additional 198 patients with SG were prospectively enrolled. Covariate imbalance was controlled using propensity score matching. Outcomes were evaluated using regression analysis clustered by type of surgery.
The SG group had lower mean levels of postoperative 24-hr blood glucose than the CG group (β =-8.6 mg/dL; 95% CI (-16.5 to -7.9), =0.042). In SG group, the incidence of ICU admission and of acute kidney injury after surgery was lower than in the CG group (OR 0.36; 95% CI (0.18-0.74), =0.005 and OR=0.59; 95% CI (0.41-0.85), =0.005, respectively). There was no significant difference in postoperative hypoglycemia, infection, cardiovascular complications, stroke, or mortality rate between the two groups.
For type 2 diabetes patients undergoing elective surgery, the SG protocol is more effective in controlling blood glucose. The protocol can also reduce the incidence of some postoperative complications compared to CG with no increased risk of hypoglycemia.
优化术后血糖控制可将术后并发症降至最低。我院一直常规使用的传统围手术期血糖控制方案(CG)缺乏详细的围手术期血糖管理措施。为此设计了一种新的标准化血糖控制方案(SG),该方案采用术后频繁监测血糖、更严格的目标血糖控制以及术前调整胰岛素剂量。本研究比较了CG和SG这两种方案在术后血糖控制效果及并发症方面的差异。
本研究纳入了380例接受择期手术的2型糖尿病患者。其中,182例采用CG方案的患者通过回顾性分析被确定为历史对照队列。另外前瞻性纳入了198例采用SG方案的患者。使用倾向得分匹配法控制协变量不平衡。通过手术类型聚类的回归分析评估结局。
SG组术后24小时血糖平均水平低于CG组(β=-8.6mg/dL;95%CI(-16.5至-7.9),P=0.042)。SG组术后入住重症监护病房(ICU)及急性肾损伤的发生率低于CG组(OR=0.36;95%CI(0.18-0.74),P=0.005;OR=0.59;95%CI(0.41-0.85),P=0.005)。两组在术后低血糖、感染、心血管并发症、中风或死亡率方面无显著差异。
对于接受择期手术的2型糖尿病患者,SG方案在控制血糖方面更有效。与CG方案相比,该方案还可降低一些术后并发症的发生率,且不会增加低血糖风险。